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Objective: IL-13/IL-4/IL-4R system has strong chondroprotective activity. We investigated polymorphisms
in these genes as potential hand osteoarthritis (OA) susceptibility loci by performing a caseecontrol
association study.
Methods: Eighteen common single nucleotide polymorphisms (SNPs) (nine in IL-4R, ﬁve in IL-4 and four
in IL-13) were genotyped in 403 patients (380 females) with hand OA and 322 healthy controls (308
females).
Results: Two SNPs (rs1805013 and rs1805015), mapping to the IL-4R gene, were associated with P-values
of 0.0116 and 0.0305 respectively in the whole sample. As far as the non-erosive hand OA group (n¼ 159)
is concerned, the signiﬁcance level of association of SNP rs1805013 is increased. After correction for
multiple testing (correction for the 54 tests) the signiﬁcance was not retained.
None of the IL-13 SNPs analyzed showed association with hand OA. Some of the analyzed SNP within the
IL-4 gene showed signiﬁcant association with hand OA only when considering subgroups of patients.
With respect to the CMC1 OA group, two SNPs in IL-4 (rs2243250 and rs2243274) showed association
with a P-value of 0.027 and 0.018 respectively. None of these associations remained after correction for
multiple testing.
Conclusions: The present study shows a trend to an association between non-erosive hand OA in
Caucasian population and a genetic variant in the coding region of IL-4R gene. Our results, in keeping
with previous data on hip OA, conﬁrm the suggestion that IL-4/IL-4R system plays a role in OA
pathogenesis. Further conﬁrmation studies on different populations are necessary.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a condition for which genetic predisposi-
tion has been intensively studied1e3. In the past 10 years a large
number of twin pairs, familial recurrence, segregation studies and
association studies have suggested the presence of major genetic
components underlying a complex mode of inheritance4e11.Riccardo Meliconi, Rheuma-
Tissue Regeneration, Istituto
na, Italy. Tel: 39-516366803;
Ospedale Maggiore, Bologna,
s Research Society International. POA can affect different skeletal sites such as knee, hip, hand and
spine.All genetic studies hitherto conductedhave generateddifferent
results for different sites, which suggest site-speciﬁc genetic inﬂu-
ence for OA10. As for most complex diseases, both inherited genetic
variations and environmental inﬂuences combine to inﬂuence the
disease risk. Among the recognized environmental factors for OA are
gender, obesity, joint instability, repetitive injury (microtrauma)with
overloading of joints, and loss of muscle mass and strength. Never-
theless many people exposed to adverse lifestyle factors do not
develop the disease, suggesting that there are susceptibility and
resistance factors which mediate the risk of environmental inﬂu-
ences, such as chondrocyte and bone cell response to various
mechanical and molecular stimuli12. All these phenomena are
genetically determined and involve the precise regulation of enzyme
and cytokine production which are the major responsible of the
imbalance between chondrocyte anabolic and catabolic activities13.ublished by Elsevier Ltd. All rights reserved.
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mechanical stress mediated by the interleukin-4/interleukin-4
receptor (IL-4/IL-4R) system. Cartilage chondrocytes function and
integrity are regulated by mechanical stimulation and IL-4 is
a major active autocrine/paracrine signalling molecule in this
mechanotransduction pathway14,15. In order to initiate signalling,
IL-4 binds to the IL-4Ra chain, which then forms heterodimers
either with the common γ chain to form type 1 receptor or with the
IL-13Ra1 subunit to form type 2 receptor. It has been proposed that
the latter form of IL-4R can be activated by both IL-4 and IL-1316.
Formation of the different receptor types results in the activation of
alternative downstream signalling pathways. IL-4 and IL-13 are
strong chondroprotective cytokines and it is reasonable to specu-
late that polymorphisms within their genes or their receptor genes
may be risk factors for OA.
Previous studies have suggested that the allelic variations of the
genes of IL-4/IL-4R system are related to chondrocyte response to
mechanical stimulation. Different single nucleotide poly-
morphisms (SNPs) in IL-4R gene have an assessed functional role in
regulating signal transduction downstream this receptor. In
particular rs1805015 (S503P) and rs1801275 (Q576R) can affect the
binding and phosphorylation of the intracellular substrates STAT6
and IRS17. Soluble IL-4R protein levels is regulated by a variant
(rs2057768, 589C/T) mapping in the 50 promoter region of this
gene18. In addition, among the different susceptibility loci for OA
identiﬁed so far through linkage analysis, a susceptibility locus for
hip OA maps on chromosome 16p2.3ep12.1 in a region containing
the IL-4Ra chain gene6,19. Four different non-synonymous coding
SNPs of IL-4R (S436L, S503P, Q576R, S752A) from this region were
found associated with an increased risk for hip OA19.
We therefore investigated polymorphisms in these genes as
potential hand OA susceptibility loci by performing a caseecontrol
association study with 18 common SNPs: ﬁve in IL-4 (NM_000589),
nine in IL-4R (NM_000418) on chromosome 16 and four in IL-13
(NM_002188) on chromosome 5.
Patients and methods
Patients
A total of 403 Caucasian patients (23 males and 380 females, age
range 41e84 years, mean 64 years) were recruited by three Rheu-
matological Centres in Italy (Bologna, Padova, Siena). In addition
322 Caucasian controls (14 males, 308 females, age range 42e84
years, mean 62 years) were selected among unrelated individuals
showing no clinical signs of osteoarticular disorders who attended
orthopaedic or rheumatologic outpatient clinics of the Rizzoli
Orthopaedic Institute (Bologna) for minor non-speciﬁc complaints.
From all patients past and present medical history was taken
and detailed musculoskeletal examinationwas performed, in order
to exclude patients with inﬂammatory arthritides and/or with
psoriasis or with positive family history of psoriasis. Clinical OA in
other sites (hip20, knee21) was also recorded. Radiographs of hip
and knee were obtained when clinical involvement was detected.
Plain hand radiographs were obtained from all patients. Hand OA
diagnosis was made according to the American College of Rheu-
matology Clinical Criteria for Hand OA22.
All radiographs were scored for joint damage following the
KellgreneLawrence and the Kallman scores21,22: two rheumatolo-
gists, with experience in hand radiograph scoring, assessed X-ray
ﬁlms together at the same time; the readings were jointwise; the
sums of single joint scores from each patients were obtained and
used in statistical analysis. When necessary, consensuswas reached
by discussion and agreement. The second reading was carried out
on the ﬁrst 30 consecutive X-rays and intraclass coefﬁcient valuesfor intrareader reliability for KellgreneLawrence scores at a single
joint was 0.985 (0.983e0.988) and for Kallman was 0.988
(0.986e0.990). In addition to KellgreneLawrence and Kallman
scores, we also utilized the scores relating to osteophytes and to
joint space narrowing (items of Kallman score). X-ray readers were
unaware of the genetic results.
Patients were then divided into erosive and non-erosive hand
OA subsets according to the presence or absence of well deﬁned
typical erosive changes (gull-wing and saw-tooth appearance) in
two or more digits. In this way we identiﬁed 197 patients with the
erosive form (14 males, 183 females, age range 44e83 years, mean
64 years). In the non-erosive formwe included 159 patients with no
sign of erosion anywhere (9 males, 150 females, age range 43e84
years, mean 62 years). Therefore 47 patients were left after this
selection because they showed an intermediate form (either
erosion in one digit, or less typical or initial form of gull-wing/saw-
tooth pattern). First carpometacarpal joint (CMC1) OA was present
in 166 patients. Finally among the total patient population, 59 cases
had concurrent hip OA and 95 concurrent knee OA.
Venous blood was drawn from each patient/control between
9.00 and 12.00 AM and immediately processed for DNA extraction.
Ethical approval for the study was obtained from appropriate
ethics committees and informed written consent was obtained
from all subjects.Genotyping
DNAwas extracted fromwhite blood cells from plasma samples
by means of the DNA Isolation Kit for Mammalian Blood (Roche,
Indianapolis, IN). DNA was quantiﬁed with PicoGreen dsDNA
Quantization Kit (Molecular Probes, Eugene, OR).
Genotyping was performed using TaqMan SNP Genotyping
Assays (Applied Biosystems). For each marker 20 ng of DNA was
ampliﬁed in a 10 ml reaction volume on a Applied Biosystems 7500
Fast Real-Time PCR System. TaqMan Pre-Designed Assays had
been used for 15 SNPs and Custom TaqMan SNP Genotyping
Assays had been used for the remaining three SNPs. Additional SNP
details are provided in Table I. The cycling parameters used for
TaqMan reactions is as follows: 95C for 10 min; 40 cycles of 95C
for 15 s followed by 60C for 1 min.Statistical analysis
The KruskaleWallis ANOVA analysis (for unpaired and non-
parametric data) and Dunn's multiple comparison correction test
was applied to compare radiological scores among OA patients
subgroups classiﬁed according tomajor andminor allele carriage of
IL-4R SNP rs1805013. Analysis was performed using GraphPad
Prism for Windows (CA, USA).
Genotype and allele frequencies were compared between OA
cases and controls using Plink software (http://pngu.mgh.harvard.
edu/purcell/plink/)23, and odds ratios (ORs) and 95% conﬁdence
intervals (95% CIs) were calculated. Correction for multiple testing
was performedwith Plink which generate the adjusted signiﬁcance
values by using Bonferroni, Holm and Sidak correction methods.
Independent effect of associated SNPs has been evaluated
using Plink. HardyeWeinberg (HW) equilibrium, and haplotype
frequencies were estimated from the genotype data using Haplo-
view software, which uses the expectation-maximization (EM)
algorithm24. Pair-wise linkage disequilibrium (LD) in our sample
between the individual SNPs was calculated using the LD-plot
function of this software. Comparisons of the distributions of allele,
genotype and haplotype frequencies were performed using the
chi-square test. SNPs with a call rate <95% or departure from HW
Table I
Data quality table for the input ﬁle. For each SNP it is indicated the TaqMan SNP Genotyping Assays assay ID when a Pre-Designed SNP Assays has been used (assay ID), the
alleles (for each SNP the two allele are indicated as major allele: minor allele), the gene, the NCBI SNP database ID (dbSNP ID), the locationwithin the genewith the amino acid
substitution when a coding SNP has been studied (location), HW equilibrium P-value in the control group (HW P-value) and the minor allele frequency (MAF)
Assay ID Alleles Gene dbSNP ID Location HW P-value Call rate MAF
C_11740467_10 A:C IL-13 rs1881457 Promoter (1512) 0.2667 98.8 0.194
C_8932056_10 C:T IL-13 rs1800925 Promoter (1112) 1 99.2 0.196
Custom Assays G:A IL-13 rs20541 Exon 2 (R144Q) 0.8326 95.7 0.186
Custom Assays G:A IL-13 Exon (þ4738) 0.632 99.2 0.187
C_16176216_10 C:T IL-4 rs2243250 Promoter (589) 0.5025 99.9 0.121
C_16176215_10 C:T IL-4 rs2070874 5'UTR(33) 0.3079 98.6 0.116
C_11818513_1_ G:T IL-4 rs2227284 Intron 2 (þ3353) 0.0903 97 0.229
C_15751521_10 G:A IL-4 rs2243266 Intron 2 (þ4417) 0.5027 98.6 0.111
C_16176468_10 G:A IL-4 rs2243274 Intron 2 (þ5460) 0.3294 99.2 0.122
C_2769607_10 C:T IL-4R rs2057768 Promoter (3223) 0.321 97.7 0.265
Custom Assays C:T IL-4R rs2107356 Promoter (1914) 0.153 96.7 0.43
C_2769554_10 A:G IL-4R rs1805010 Exon 6 (I75V) 1 99.6 0.443
C_2769552_10 C:T IL-4R rs3024571 Exon 7 (N167N) 0.6762 99.7 0.109
C_8903098_20 A:C IL-4R rs1805011 Exon12 (E400A) 0.8524 99 0.082
C_8903093_10 C:T IL-4R rs1805013 Exon12 (S436L) 0.317 99.4 0.067
C_8903092_20 T:C IL-4R rs1805015 Exon12 (S503P) 0.3763 99 0.177
C_2351160_20 A:G IL-4R rs1801275 Exon12 (Q576R) 0.9775 99.9 0.186
C_8903091_10 T:G IL-4R rs1805016 Exon12 (S752A) 1 98.5 0.074
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from the ﬁnal analysis.Results
All 18 SNPs conformed to the HW equilibrium in the control
group (P> 0.05) (Table I).
The caseecontrol association analysis was performed ﬁrst on
the whole sample regardless of the gender and the clinical features,
and only two SNPs (rs1805013 and rs1805015), mapping to the
IL-4R gene on chromosome 16, were associated with P-values of
0.0116 and 0.0305 respectively (Tables II and III). This association
was attributable to an increased occurrence in the affected indi-
viduals of the minor allele, the T and C alleles respectively, at these
SNPs. The IL-4R SNP rs1805013 has been already reported associ-
ated with an increased risk of hip OA19. As some of our patients
developed also hip OA, we wondered whether our association
results were due to this small subgroup of patients. However, the
association with this SNP was maintained also when subtracting
from the whole sample the patients who developed hip OA
(P-value¼ 0.017) (Tables II and III). When considering only patients
not developing knee OA, the association remains still signiﬁcant for
this SNP (data not shown).
According to the presence or absence of well deﬁned typical
erosive changes in two or more digits, patients were divided into
erosive and non-erosive hand OA subsets. As far as the non-erosive
hand OA group (n¼ 159) is concerned, the signiﬁcance level of
association of SNP rs1805013 showed an increase with a P-value of
0.002 and it showed a nominally signiﬁcant P-value after correction
for multiple testing (P-value¼ 0.018; OR¼ 2.206 [95%
CI¼ 1.32e3.68] after correction for nine tests [number of markers
tested for the IL-4R gene]; non-signiﬁcant after correction for 54
tests [total number of multiple tests done]). In addition, also the
other SNP of IL-4R gene, rs1805015, showed an increased associa-
tion with a P-value of 0.006 (Tables II and III) and it did not retain
signiﬁcance after correction for multiple testing. In the erosive
hand OA group (n¼ 197) none of the two SNPs rs1805013 and
rs1805015 showed association (Tables II and III).
When considering the distribution of SNP rs1805013 according
to the radiological damage scores, no signiﬁcant differences were
observed among patients homozygous for the major allele,
heterozygous and homozygous for the minor allele (Table IV).CMC1 OA is a particular subtype of hand OA which develops at
the base of the thumb. In this subgroup (n¼ 166), none of the IL-4R
SNPs approached the signiﬁcance threshold (Table II).
None of the IL-13 SNPs analyzed showed association with hand
OA.
Some of the analyzed SNP within the IL-4 gene showed signif-
icant associationwith hand OA onlywhen considering subgroups of
patients. With respect to the CMC1 OA group, two SNPs in IL-4
(rs2243250 and rs2243274) showed association with a P-value of
0.027 and 0.018 respectively (Table II). These associations were
attributable to an increased frequency in the probands of the minor
allele at these SNPs. These two SNPs rs2243250 and rs2243274
approached the signiﬁcativity threshold also when considering
only patients with a non-erosive phenotype with a P-value of 0.048
and 0.023, respectively (Table II). None of these SNPs remains
signiﬁcantly associated after correction for multiple testing.
The pair-wise LD coefﬁcient r2 was calculated for all SNPs by
using data from all cohorts genotyped (cases, cases and controls
combined). With respect to chromosome 16, moderate LD could be
detected (Fig. 1).
With respect to chromosome 5, this revealed strong LD between
rs1881457 and rs1800925 with an r2 of 0.86. These SNPs are both in
the promoter of IL-13, in position 1512 and 1112, respectively. In
addition, strong LD is present among all the SNPs of IL-4. As
expected, there is no LD between IL-13 and IL-4 genes (Fig. 1).
Analyses for haplotypes did not reveal any statistically signiﬁcant
signals.Discussion
We investigated the association between polymorphisms in
a series of patients with hand OA in three candidate genes of the
IL-4/IL-4R system: IL-4R, IL-4, IL-13.
We found a positive association with two SNPs in the gene
encoding IL-4Ra chain (rs1805013 and rs1805015) in the whole
sample of OA patients. Remarkably, this association sharply
increases when considering the patients with non-erosive hand OA
and the association for rs1805013 remains signiﬁcant also after
correction for multiple testing. From our results, the non-erosive
hand OA phenotype is associated with the T allele of SNP rs1805013
whereas this association disappeared when considering the more
severe erosive phenotype. This result suggests that other
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Table III
Genotype and allele frequencies of the polymorphisms rs1805013 and rs1805015 in
the IL-4R gene between cases and controls
Whole sample n (%) No hip n (%) Non-erosive n (%)
Controls
(n¼ 322)
Cases
(n¼ 403)
Controls
(n¼ 322)
Cases
(n¼ 354)
Controls
(n¼ 322)
Cases
(n¼ 159)
rs1805013
Genotype
CC 290 (90.1) 348 (86.4) 290 (90.1) 306 (86.4) 290 (90.1) 133 (83.6)
CT 27 (8.4) 37 (9.2) 27 (8.4) 32 (9) 27 (8.4) 18 (11.3)
TT 2 (0.6) 14 (3.5) 2 (0.6) 12 (3.4) 2 (0.6) 7 (4.4)
Allele
C 607 (94.3) 733 (90.9) 607 (94.3) 644 (91) 607 (94.3) 284 (89.3)
T 31(4.8) 65 (8.1) 31(4.8) 56 (7.9) 31(4.8) 32(10.1)
rs1805015
Genotype
TT 230 (71.4) 256 (63.5) 230 (71.4) 228 (64.4) 230 (71.4) 95 (59.7)
TC 76 (23.6) 126 (31.3) 76 (23.6) 108 (30.5) 76 (23.6) 55 (34.6)
CC 11 (3.4) 15 (3.7) 11 (3.4) 13 (3.7) 11 (3.4) 8 (5)
Allele
T 536 (83.2) 638 (79.2) 536 (83.2) 564 (79.7) 536 (83.2) 245 (77)
C 98 (15.2) 156 (19.4) 98 (15.2) 134 (18.9) 98 (15.2) 71 (22.3)
M. Vargiolu et al. / Osteoarthritis and Cartilage 18 (2010) 810e816 813susceptibility genetic factors might probably be associated to the
erosive phenotype. Anyway, the signiﬁcance observed in the whole
sample is not completely due to the non-erosive hand OA patients,
as the distribution of the genotype at these SNPs did not signiﬁ-
cantly differ when comparing the erosive and non-erosive
subgroups. In addition, when considering SNP rs1805013, we did
not ﬁnd any correlation between the T allele carrier status and
radiological damage evaluated by two different score systems.
Consequently, we suggest that SNP rs1805013 is not associated to
disease severity but only to disease susceptibility.
The associated Tallele of SNP rs1805013 results in an amino acid
substitution of serine 436 with leucine in the codon of IL-4R and
consequently in the substitution of a polar hydrophilic residuewith
an aliphatic hydrophobic one, a change that may have effects on
protein functions. Functional studies for the S436L substitution
have not been reported yet and they might clarify its role in
chondrocytes mechanotransduction.
Polymorphisms in the IL-4R gene had been found associated
with hipOA in a study published by Forster et al. in 200419. Forster et
al. tested nine SNPs within the IL-4R gene and found a signiﬁcant
association for two of them (S411L, here S436L, rs1805013, and
S727A, here S752A, rs1805016)withhipOA. This genetic association
was weak and did not incorporate a correction for multiple
comparisons. In our study, we investigate all the nine SNPs already
studied by Forster et al. in order to verifywhether their results could
be supported in our sample of hand OA. Our study broadly supports
IL-4R gene polymorphisms association with OA. It is noteworthy
that in the present study the associationwe found cannot retain its
signiﬁcance after multiple testing correction. In the hip OA study,
the strongest association found was with SNP rs1805016 (S752A),
but no associationwith this SNP, even at subgroup analysis level and
also before multiple testing correction, was found in our study,
suggesting that different loci inside the IL-4/IL-4R system may be
involved in hip and hand OA susceptibility.
Interestingly, the analyzed markers surrounding rs1805013 did
not show a signiﬁcantly high LD with this SNP, suggesting that
other untested polymorphisms in this region could be possibly
associated to hand OA. Instead, the strong LD found in the other
two genes suggests that no other associated variants should be
present in our sample population. It is worth noting that our results
are speciﬁc to Caucasian populations and the effects in other
populations are unknown.
Table IV
Radiographic score in OA patients dividing according tomajor andminor allele carriage of IL-4R SNP rs1805013. Radiographic score values are expressed asmedian (25the75th
percentiles)
Radiological score Major allele (n¼ 351) Minor allele (heterozigote) (n¼ 38) Minor allele (homozigote) (n¼ 14) P-value
KellgreneLawrence 26.0 (17.0e40.0) 24.0 (13.0e44.0) 26.0 (17.0e34.0) ns*
Kallman, global score 86.0 (68.0e103.0) 84.0 (72.0e112.0) 86.5 (73.0e96.5) ns*
Osteophyte score 21.0 (14.0e28.0) 21.0 (14.0e34.0) 22.0 (11.0e27.0) ns*
Joint space narrowing score 19.0 (14.0e27.0) 21.0 (13.0e33.0) 21.0 (17.0e27.0) ns*
* ns, no signiﬁcant difference among groups.
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using a different OA outcome. A recent review failed to ﬁnd genetic
association between IL-4R and hip OA25. Various factors may have
contributed to the discordant results among studies, including
differences in the studied phenotypes and the genetic environment
and, more speciﬁcally, failure to take into account factors that
modulate the effect of a gene on the risk of OA. One explanation for
the divergent ﬁndings may also be that, since different joints are
under dissimilar loading, they may also have different causes for
development of OA. For instance, the hip and knee are weight-
bearing joints whereas hand joints are under very different usage
and load.
Polymorphisms in IL-4 and IL-13 genes had been reported in
patients with immune mediated disorders26, but so far no associ-
ation study has been conducted in patients with OA.
For IL-4 gene polymorphisms, no association was found in our
total population. Conversely two SNPs were associated with the
CMC1 OA subset. Even though this association does not remain
statistically signiﬁcant after correction for multiple testing, our
results show for the ﬁrst time a possible association between CMC1
OA and polymorphisms in the genes of the IL-4/IL-4R system. No
association was observed with the four IL-13 SNPs.
We are aware of the small sample size and of the weakness of
the association we found for IL-4 polymorphisms and CMC1 OA.
The present study may encourage to further study the relationship
between this particular phenotype of hand OA and genes of the
IL-4/IL-4R system in larger case series.
For this analysis we relied on strict criteria to identify very clear
cut subpopulation groups, thus excluding from subgroup analyses
the patients with intermediate radiological features. We are aware
of the strong limitations and caveats inherent to subgroup analysis,
therefore conﬁrmation studies in independent populations areFig. 1. Haploview output showing LD relationships between the 18 SNPs of IL-4R (chromoso
pair of SNPs e darker colours indicate higher values.warranted on erosive and non-erosive hand OA subsets, as well as
for CMC1 subset.
An issue that we do not have the opportunity to consider is the
gender effect, which could have not been evaluated given the small
number of male subjects in our sample. Further studies with
a larger series of patients will allow the evaluation of the gender
effect on this genetic association.
Association studies of several genes have attempted to
elucidate the genes in which genetic variation contributes to
hand OA susceptibility. There are many potential candidate
genes for hand OA. So far only three genes (A2BP126, ENPP127
and HFE28) showed convincing association signals or have
been reported to be associated with hand OA in at least two
independent samples. Other candidate genes such as and the
interleukin-1 genes (IL-1A, IL-1B and IL-1RN29), the gene for the
major collagen in cartilage (COL2A130), interleukin-6 (IL-631),
insulin-like growth factor I gene (IGF-132), vitamin D receptor
(VDR33) and the disintegrin and metalloproteinase domain 12
(ADAM1234) to date have been investigated in one or two studies
and have showed suggestive genetic association with weak
association signals rarely replicated in independent studies.
Similarly to these studies, our results suggest a weak genetic
association. On the other hand, our results rely on a small
sample whereas some of these association studies have been
performed on larger samples.
The present study is an attempt to replicate genetic association
for genes IL-4/IL-4R system. Our results show an association
between a genetic variant in the coding region of IL-4R gene and
hand OA in Caucasian population. Although our study, in keeping
with previous data on hip OA19, conﬁrms the suggestion that IL-4/
IL-4R system plays a role in OA pathogenesis, this genetic associa-
tion requires conﬁrmation in well powered studies.me 16), IL-4 and IL-13 (chromosome 5). The matrix indicates the D0 value between each
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